Buffalo diagnostics company Empire Genomics is readying itself to acquire new technologies, grow its staff and increase its test offerings.
It plans to do so with $1 million in recent financing from Rand Capital and Buffalo-area incubator Z80 Labs.
Empire Genomics was launched in 2006 at the Roswell Cancer Institute in Buffalo, New York. The lab develops high throughput technologies to allow for genome-wide analyses aimed at understanding the underlying mechanisms that cause disease, particularly cancer.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The company has been planning for some time now to grow its employee count — it announced a five-year plan in 2012 to add 50 new workers to its offices that border the Buffalo Niagara Medical Campus.
Earlier this year, Empire Genomics was included in a $105 million genomic research consortium funded by the state of New York that’s made up of companies in both Buffalo and Manhattan.